CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 7 of the 18 sources its claims cite were checked for support.
Abstract
Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease that can progress to liver fibrosis. Recent clinical advance suggests a reversibility of liver fibrosis, but the cellular and molecular mechanisms underlying NASH resolution remain unclarified. Here, using a murine diet-induced NASH and the subsequent resolution model, we demonstrate direct roles of CD8+ tissue-resident memory CD8+ T (CD8+ Trm) cells in resolving liver fibrosis. Single-cell transcriptome analysis and FACS analysis revealed CD69+CD103−CD8+ Trm cell enrichment in NASH resolution livers. The reduction of liver CD8+ Trm cells, maintained by tissue IL-15, significantly delayed fibrosis resolution, while adoptive transfer of these cells protected mice from fibrosis progression. During resolution, CD8+ Trm cells attracted hepatic stellate cells (HSCs) in a CCR5-dependent manner, and predisposed activated HSCs to FasL-Fas-mediated apoptosis. Histological assessment of patients with NASH revealed CD69+CD8+ Trm abundance in fibrotic areas, further supporting their roles in humans. These results highlight the undefined role of liver CD8+ Trm in fibrosis resolution.
Overview
CoChat Summary
TL;DR
In a murine diet-induced NASH resolution model, CD8+ tissue-resident memory T (Trm) cells accumulate in the liver and promote fibrosis resolution by targeting hepatic stellate cells (HSCs). The proposed mechanism involves CCR5-dependent chemoattraction and FasL-Fas-mediated HSC apoptosis, with IL-15 maintaining the liver CD8+ Trm population.
Key findings
- Liver CD8+ T cells remained elevated during NASH resolution; depleting CD8+ T cells prevented recovery from inflammation and fibrosis, increased HSCs, and did not affect macrophage numbers.
- Single-cell RNA sequencing of 25,851 liver CD8+ T cells resolved 17 clusters; >60% of normal-diet CD8+ T cells were naïve, whereas resolution livers were enriched for CD69+CD103−CD8+ Trm cells. Parabiosis and scTCR-seq indicated these cells were tissue-resident and liver-derived rather than spleen-recruited.
- IL-15 neutralization reduced liver CD8+ Trm cells and significantly inhibited fibrosis resolution; RES CD8+ Trm adoptive transfer protected MCD diet-fed mice from fibrosis progression.
- CD8+ Trm cells attracted HSCs in a CCR5-dependent manner, and induced HSC apoptosis via FasL-Fas; HSC-specific CCR5 knockdown or anti-FasL treatment attenuated resolution. In human liver samples from 13 NASH patients and 5 controls, CD69+CD8+ Trm cells increased with fibrosis progression (n = 5 normal control, n = 4 F1-2, n = 9 F3-4).
Methods
- Male C57BL/6 mice were fed a high-fat high-cholesterol (HFHC) diet for 24 weeks, then continued HFHC or switched to normal diet for 2–8 weeks; a methionine choline deficient (MCD) diet model was also used for 7 weeks followed by normal diet.
- Liver immune cells, HSCs, and hepatocytes were analyzed by flow cytometry, cell sorting, scRNA-seq, scTCR-seq, bulk RNA-seq, parabiosis, adoptive transfer, antibody/inhibitor treatments, migration assays, and LDH-based cytotoxicity assays.
- Human liver tissues from NASH patients and controls were assessed by immunohistochemistry for CD69+CD8+ T cells. Statistical comparisons used one-way ANOVA with Tukey’s post-hoc test or two-sided unpaired Student’s t test, with significance at p < 0.05.
Limitations
- Stated in the paper: further studies are warranted to identify the specific antigens driving liver CD8+ Trm development, and the actual contribution of granzyme A to fibrosis resolution remains to be clarified.
- Evident from the text: human evidence is correlative and limited to 13 NASH patients plus 5 controls, with no functional human experiments; mouse NASH models may not fully recapitulate human disease.
- Evident from the text: several mouse experiments used small group sizes (often n = 3–8 per group), which may limit statistical power and generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
3 Valid · 0 Not valid · 5 Not checked · 76 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, bulk RNA-seq analysis of isolated cells (ND naïve, HFHC Tem, HFHC Trm, and RES Trm) revealed that both Trm subsets from HFHC mice and RES mice expressed core signature genes of Trm21–24 with exceptions including Itgae (CD103) and Eomes (Fig. 4d).”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Results > Involvement of liver CD8+ Trm cells in liver fibrosis resolution
What the sources say
- Not checked yetcites [21] Mackay, L. K. et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294–1301 (2013). source
- Could not verifycites [22] Kragten, N. A. M. et al. Blimp-1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 T cells. Eur. J. Immunol. 48, 1644–1662 (2018). sourceExperimental — accuracy not yet measured
Our copy of Kragten et al. 2018 contains no high-fat/high-cholesterol (HFHC) or resveratrol (RES) mouse model and no bulk RNA-seq of ND/HFHC Tem/HFHC Trm/RES Trm subsets; its only RNA-seq (Methods, 'RNA sequencing') is of LCMV-specific CD8 T cell subsets at day 40+ post-infection, and its Fig. 4 (Hobit drives granzyme B expression during the memory phase in Trm, p. n/a) concerns granzyme B in Hobit KO liver/gut Trm after LCMV-WE. Searches for 'HFHC/resveratrol/diet', 'Itgae CD103 Eomes signature genes', and 'naive bulk RNA-seq Fig. 4d' returned nothing addressing the claimed experiment, so the paper neither supports nor contradicts the statement; the citing sentence's own Fig. 4d evidently belongs to a different study. (LLM, conf=0.70)
- Could not verifycites [23] Cheuk, S. et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity 46, 287–300 (2017). sourceExperimental — accuracy not yet measured
Our copy of Cheuk et al. 2017 is a human study only: its bulk RNA-seq (Results, 'Transcriptional Profiles of Epidermal CD8+CD103+CD49a– and CD8+CD103+CD49a+ Trm Cells Indicate a Functional Dichotomy', Figures 2A–2G) compares sorted human epidermal, dermal and blood T cell subsets from healthy donors, and both subsets analysed are CD103+ by definition, with qPCR confirming 'no difference in ITGAE, encoding CD103'. No passage reports RNA-seq of naïve, Tem or Trm cells from high-fat/high-cholesterol (HFHC) or resiquimod (RES)-treated mice, and Eomes is never mentioned (searches: Itgae/CD103 core signature genes, Eomes, HFHC/resiquimod mouse models, mouse Trm transcriptional programs). Mouse work appears only as cited background (Gebhardt et al. 2009, Zaid et al. 2014, Mackay et al. 2013, Zhang & Bevan 2013, Discussion), so the attributed experiment is not this paper's, but our copy names no single source for it and does not contradict it either. (LLM, conf=0.70)
- Could not verifycites [24] Khan, O. et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature 571, 211–218 (2019). sourceExperimental — accuracy not yet measured
Our copy of Khan et al. (2019) is entirely about TOX in LCMV Armstrong/Clone-13 CD8+ T cell exhaustion: no passage mentions HFHC or RES diet models, tissue-resident memory (Trm) subsets sorted for bulk RNA-seq, or Itgae/CD103 (searched: 'HFHC Itgae CD103 tissue-resident Trm RNA-seq', 'Trm signature genes CD69 CD103 liver', 'TOX OE cKO Eomes'). Eomes appears only in the exhaustion/memory context (e.g. 'Eomes was reduced in the absence of TOX', Results p. section 'An essential role for TOX in the generation of TEX'; Extended Data Figs. 2-3), which does not address the claim's Trm gene-signature comparison. The Methods ('RNA and ATAC-seq sample preparation and sequencing') list only P14 cells from spleen, transduced T cells and NIH3T3 fibroblasts — no hepatic Trm populations. Nothing in our copy supports or contradicts the attributed finding, and no alternative source is named for it. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“while not prevented in mice depleted of natural killer (NK) cells and NKT cells (Supplementary Fig. 2a–d), other known antifibrotic cell subsets19,20, nor in mice depleted of conventional dendritic cells (DCs) or plasmacytoid DCs (Supplementary Fig. 2e–h), a part of which express CD8.”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Results > Involvement of liver CD8+ Trm cells in liver fibrosis resolution
What the sources say
- Could not verifycites [19] Jeong, W. I. et al. Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 53, 1342–1351 (2011). sourceExperimental — accuracy not yet measured
Our copy of Jeong et al. (2011) contains no NK-cell or NKT-cell depletion experiment and no recovery/resolution model: its in vivo work is poly I:C or IFN-γ treatment of 2-week vs 10/12-week CCl4 mice (Results, 'Poly I:C or IFN-γ treatment does not ameliorate advanced liver fibrosis'; 'Poly I:C-mediated activation of NK cells is diminished...'), plus IFN-γ−/− and IFN-γ−/−SOCS1−/− mice and HSC co-cultures (Materials and Methods, 'Animals'). Searches for 'anti-asialo GM1/depletion', 'NKT cells', 'recovery/resolution' and 'collagen/hydroxyproline after NK depletion' returned only passages about diminished NK activation and the suppression of NK cell/IFN-γ antifibrotic signalling in advanced fibrosis (Discussion; Abstract Conclusion), nothing stating that depleting NK/NKT cells did or did not prevent recovery from inflammation and fibrosis. The claim therefore rests on another study (the citing sentence's Supplementary Fig. 2a-d depletion data), not on this paper. (LLM, conf=0.72)
- Partly supportedcites [20] Park, O. et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49, 1683–1694 (2009). sourceExperimental — accuracy not yet measured
Our copy supports only the NKT half, and at a different condition: the Abstract and Results ('iNKT cells play a role in inhibiting liver fibrosis in the early stage but not late stage...', and the Discussion 'Diverse roles of iNKT cells in liver fibrosis') report that iNKT-deficient (Jα18-/-) mice, and chronic-CCl4-treated wild-type mice whose hepatic iNKT cells were depleted, developed a similar degree of liver injury and, at 4 weeks, a similar grade of fibrosis. The NK half is absent — the paper never depletes NK cells (it states total NK cell numbers were increased after CCl4, and its antifibrotic NK claims are credited to refs 7–10) — and no recovery/resolution experiment exists in our copy: all endpoints are measured during ongoing CCl4 administration (2 or 4 weeks), not after cessation. So 'recovery from liver inflammation and fibrosis' and 'mice depleted of NK cells' are not supported by this source. (LLM, conf=0.66)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As downregulation of Eomes is required for CD103+CD8+ Trm development via TGF-β signaling32, insufficient local TGF-β signaling may result in sustained high Eomes expression and an abundance of CD103−CD69+CD8+ Trm cells in the liver, consistent with previous reports28,33.”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Discussion
What the sources say
- Partly supportedcites [32] Wakim, L. M., Smith, J., Caminschi, I., Lahoud, M. H. & Villadangos, J. A. Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection. Mucosal Immunol. 8, 1060–1071 (2015). sourceExperimental — accuracy not yet measured
Our copy of Wakim et al. (2015) supports only the TGF-β arm of the cited clause: the Results section 'CD103+ DCs promote CD103 upregulation upon CD8 T-cell activation in a TGFβ-dependent manner' (and Figure 3/Figure 4 legends) show maintenance of CD103 on OT-I cells is blocked by anti-TGFβ antibody and that TGFβR−/− OT-I cells fail to upregulate CD103 or accumulate in lung parenchyma, with the Discussion stating TGFβ signalling is required for Trm development in lung, gut, skin and genital mucosa. However, no passage in our copy mentions Eomes (or Eomesodermin) at all — searched 'Eomes', 'Eomesodermin', 'downregulation of Eomes' — so the mechanistic step the citing sentence attributes to reference 32 (Eomes downregulation being required, via TGF-β signalling) is not supported by this source. The liver-specific inference (CD103−CD69+CD8+ Trm abundance in liver) is likewise absent; this paper studies lung only. (LLM, conf=0.68)
- Not checked yetcites [28] Fernandez-Ruiz, D. et al. Liver-resident memory CD8(+) T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889–902 (2016). source
- Not checked yetcites [33] Kim, J. H. et al. Functions of human liver CD69(+)CD103(−)CD8(+) T cells depend on HIF-2alpha activity in healthy and pathologic livers. J. Hepatol. 72, 1170–1181 (2020). source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In this regard, our current results, along with the previous findings28,35, suggest that chemokine receptor CXCR3 and CXCR6 may be required for the localization.”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Discussion
What the sources say
- Not checked yetcites [28] Fernandez-Ruiz, D. et al. Liver-resident memory CD8(+) T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889–902 (2016). source
- Partly supportedcites [35] Curbishley, S. M., Eksteen, B., Gladue, R. P., Lalor, P. & Adams, D. H. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am. J. Pathol. 167, 887–899 (2005). sourceExperimental — accuracy not yet measured
Our copy supports only the CXCR3 half of the attribution: the Abstract and Discussion state that CXCR3 activation promotes adhesion and transendothelial migration of liver-infiltrating (CXCR3-high, largely CD45RO+ memory, CD4:CD8 55:45) T cells across human hepatic endothelium under flow, and that 'CXCR3 is the dominant chemokine receptor mediating the recruitment of tissue-infiltrating lymphocytes in chronic inflammatory liver disease' (Discussion; Figure 5 legend). Nothing in our copy mentions CXCR6 at all (searched 'CXCR6'), and no passage addresses CD8+ tissue-resident memory (Trm) cells or their retention/localization as such — the paper studies effector/infiltrating T-cell recruitment in chronic inflammatory liver disease, not a Trm population. So the CXCR6 component and the CD8+ Trm framing of the citing sentence are not supported by this source. (LLM, conf=0.70)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We noted that both the frequency and number of intrahepatic CD8+ T cells remained significantly high in RES mice compared to normal diet (ND)-fed mice (ND mice), while other cell subsets tended to return to the normal condition (Fig. 1f, g and Supplementary Fig. 1i, j).”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Results > NASH resolution model in mice
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
44 more claims
Create a free account to see all 84 claims and to verify the 11 references still open.
- It may state two separate claims as one. 26
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In specific contexts NK, NKT, and CD8+ T cells all induce HSC apoptosis to attenuate scar deposition (21, 108, 123).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [21]
In the citing paper
“Both hepatic γδ T cells and a subset of CD8+ T cells with a resident memory phenotype display apoptotic properties toward HSCs through a Fas/FasL pathway and promote fibrosis resolution (104, 105).”
From Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy (2024) · doi:10.1146/annurev-pharmtox-020524-012013 · cites this paper as [105]
In the citing paper
“Adoptive transfer of regression-primed CD8+ memory T cells reduces the number of aHSCs and controls fibrosis (21).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [21]
In the citing paper
“iii) deactivation or elimination of myofibroblasts by reverting them to a quiescent HSC-like phenotype, via HSC senescence or by elimination of activated HSCs via NK cells or T cells 91,105,141;”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Results > Involvement of liver CD8+ Trm cells in liver fibrosis resolution
“the clusters were divided into four groups composed of Cd44−Sell+S1pr1+ naïve T cells (cluster 0, 4)”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Results > Involvement of liver CD8+ Trm cells in liver fibrosis resolution
“d Fractions of five clusters (naïve, Tcm, Tem, Trm, and others) in CD8+ T cells.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Methods > Single-cell RNA sequencing
“A gene expression heatmap showing the unbiased generation of the top 10 differentially expressed genes for each cluster (Fig. 2b).”
§ CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells > Results > Involvement of liver CD8+ Trm cells in liver fibrosis resolution
“b Representative CD4/CD8α staining of CD45+TCRβ+ NK1.1− gated liver MNCs.”
Citations
Cites
Salmon provides fast and bias-aware quantification of transcript expression
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017) · Nature Methods · doi:10.1038/nmeth.4197 · Cited by 12,700
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1325-x · Cited by 1,646
The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
Mackay, L. K., Rahimpour, A., Ma, J. Z., Collins, N., Stock, A. T., Hafon, M.-L., Vega-Ramos, J., Lauzurica, P., Mueller, S. N., Stefanovic, T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2744 · Cited by 1,331
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
Cited by
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes
Wang, T.-W., Johmura, Y., Suzuki, N., Omori, S., Migita, T., Yamaguchi, K., Hatakeyama, S., Yamazaki, S., Shimizu, E., Imoto, S., et al. (2022) · Nature · doi:10.1038/s41586-022-05388-4 · Cited by 469
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Bhattacharya, M., & Ramachandran, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01551-9 · Cited by 148
Metadata
- Authors
- Koda, Y., Teratani, T., Chu, P.-S., Hagihara, Y., Mikami, Y., Harada, Y., Tsujikawa, H., Miyamoto, K., Suzuki, T., Taniki, N., Sujino, T., Sakamoto, M., Kanai, T., & Nakamoto, N.
- Affiliations
- Keio University (JP)
- Corresponding author
- Nakamoto, Nobuhiro
- ORCID
- Venue
- Nature Communications
- Published
- 2021-07-22
- Volume
- 12
- Issue
- 1
- Pages
- 4474-4474
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8298513
- OpenAlex
- W3186843381
- Cited by
- 219
- References
- 51
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 47 · 2023: 45 · 2022: 30 · 2021: 5
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- MEXT | Japan Society for the Promotion of Science (20H04129)
- Takeda Science Foundation (NA)
- Keio University Medical Fund
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- CD8+ tissue-resident memory T cells, nonalcoholic steatohepatitis, hepatic stellate cells, CCR5, IL-15, CD69, diet-induced NASH, adoptive T cell therapy, chronic liver disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Animals, Disease Models, Animal, Female, Humans, Immunologic Memory, Liver Cirrhosis, Male, Mice, Inbred C57BL, Middle Aged, Apoptosis, CD8-Positive T-Lymphocytes, Disease Progression, Adoptive Transfer, Interleukin-15, Receptors, CCR5, Mice, Hepatic Stellate Cells, Young Adult, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. https://app.cochat.ai/papers/10.1038/s41467-021-24734-0
- The paper
- Koda, Y., Teratani, T., Chu, P.-S., Hagihara, Y., Mikami, Y., Harada, Y., Tsujikawa, H., Miyamoto, K., Suzuki, T., Taniki, N., Sujino, T., Sakamoto, M., Kanai, T., & Nakamoto, N. (2021). CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nature Communications. https://doi.org/10.1038/s41467-021-24734-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.